SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is currently trending as shareholders react to the company's annual meeting proposals, which include authorization for a potential reverse stock split. While some in the community are optimistic about Tonmya prescription growth and recent insider buying, others remain deeply skeptical, citing a long history of dilution and the stock's significant decline since its product launch.

Daddy Darth Vader

The community is currently caught in a "daddy war" rivalry between various tokens, driving intense debate over leadership credibility, alleged market manipulation, and the potential for rapid gains. Discussions are split between investors advocating for loyal community building and skeptics warning of a high-risk environment characterized by potential rug pulls and pump-and-dump mechanics.

Sezzle, Inc. engages in the operation of a digital payment platform that enables bank-to-bank transfer of money between consumers and businesses. The company was founded by Charlie G. Youakim, Killian Brackey and Paul V. Paradis on January 4, 2016 and is headquartered in Minneapolis, MN.

Sezzle Inc.

Sezzle is trending as investors weigh recent institutional moves and analyst coverage against short-term volatility following an abrupt board shakeup. The community remains focused on high short interest and anticipation for the upcoming quarterly earnings, with bulls emphasizing strong fundamental growth and potential for a short squeeze despite ongoing market fluctuations.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is experiencing heightened community debate as investors weigh strong dividend yields and favorable technical setups against ongoing concerns over pipeline growth and regulatory headwinds from potential pharmaceutical tariffs. While some traders are focused on short-term option signals and a possible breakout above key resistance, others remain skeptical, pointing to the company's historical performance and the competitive pressure in the obesity and oncology markets.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is garnering intense community focus as traders weigh long-term infrastructure potential against recent price volatility and concerns over institutional adoption. Conversations are currently polarized between believers in the project's foundational role in tokenized real-world assets and those frustrated by its recent underperformance compared to the broader market.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is seeing intense investor debate as shareholders weigh the company's defensive cash-heavy strategy against its persistent underperformance compared to the broader market. While some investors view the stock as a stable, undervalued hedge during volatility, others are increasingly vocal about frustration with management's capital allocation and a lack of aggressive growth, particularly as leadership transitions to Greg Abel.

iShares Trust - iShares China Large-Cap ETF

iShares China Large-Cap ETF

Investors are closely monitoring the iShares China Large-Cap ETF as the community debates whether the sector is approaching a tradeable market bottom amid shifting geopolitical tensions, U.S.-China trade negotiations, and internal Chinese economic policy updates. While some market participants are actively adding the symbol to watchlists and identifying potential bullish reversals, others remain cautious, pointing to persistent concerns over deflation, property market instability, and the impact of looming tariff threats on long-term growth prospects.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is capturing significant investor attention as it approaches critical clinical catalysts, specifically interim data for its Phase 2 study of KYV-101 in generalized myasthenia gravis and upcoming presentations on stiff-person syndrome. The community is actively discussing the company's strong institutional backing and the potential for a first-to-market advantage in CAR-T autoimmune therapies, with many traders viewing the current valuation as a notable entry point ahead of these milestones.

Coeur Mining, Inc. engages in the well-diversified, growing precious metals producer with a focus on generating sustainable, high-quality cash flow and returns from a balanced, prospective asset base in mining-friendly jurisdictions along with commitment to exploration and expansions. It operates through the following segments: Palmarejo, Rochester, Kensington, Wharf and Silvertip. The Palmarejo segment includes a gold-silver complex. The Rochester segment operates an open pit heap leach silver-gold mine in northwestern Nevada. The Kensington segment relates to an underground gold mine located north of Juneau, Alaska. The Wharf segment focuses on an open pit heap leach gold mine located near Lead, South Dakota. The Silvertip segment silver-zinc-lead exploration located in the state of Sonora in northern Mexico. The company was founded in 1928 and is headquartered in Chicago, IL.

Coeur Mining Inc

Coeur Mining is experiencing heightened investor interest driven by strong quarterly results, robust production forecasts, and the impending acquisition of New Gold, which community members view as a strategic catalyst for future cash flow and market re-rating. While many investors are bullish on the company's long-term potential within the precious metals sector, sentiment is currently characterized by intense debate over stock performance relative to rising gold and silver prices and the impact of the ongoing merger on share dilution.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. is trending as it positions itself as a critical player in the U.S. defense supply chain, leveraging a fully financed expansion of its heavy rare-earth metallization facility to reduce dependence on Chinese-sourced materials. The community is actively discussing the company's high-level board of directors, recent Department of Defense contracting, and the strategic importance of its domestic processing capabilities as the market prepares for 2027 mandates regarding Chinese-origin rare earth components.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lamb Weston (LW) Q3 Earnings and Revenues Top Estimates

Lamb Weston (LW) delivered earnings and revenue surprises of +18.42% and +5.40%, respectively, for the quarter ended February 2026. Do the numbers hold clues to what lies ahead for the stock?

John B. Sanfilippo & Son, Inc. Declares $1.50 Per Share Special Dividend

John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS) (the Company) today announced that its Board of Directors (the Board) declared a special cash dividend (the Special Dividend) of $1.50 per share on all...

Dean Capital Management Acquires 22,117 Shares of John B. Sanfilippo & Son, Inc. $JBSS

Dean Capital Management raised its holdings in John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS - Free Report) by 163.3% during the 3rd quarter, according to the company in its most recent filing with the...

John B. Sanfilippo & Son, Inc. $JBSS Shares Acquired by Legato Capital Management LLC

Legato Capital Management LLC lifted its holdings in John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS - Free Report) by 163.3% during the third quarter, according to the company in its most recent filing...

Royce & Associates LP Has $15.61 Million Stock Position in John B. Sanfilippo & Son, Inc. $JBSS

Royce & Associates LP cut its position in John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS - Free Report) by 14.1% during the third quarter, according to the company in its most recent disclosure with the...

John B. Sanfilippo & Son (NASDAQ:JBSS) Rating Increased to Strong-Buy at Wall Street Zen

Wall Street Zen upgraded John B. Sanfilippo & Son from a "buy" rating to a "strong-buy" rating in a research note on Saturday...

John B. Sanfilippo & Son (NASDAQ:JBSS) Sets New 12-Month High - Here's What Happened

John B. Sanfilippo & Son (NASDAQ:JBSS) Sets New 52-Week High - Time to Buy...

Implied Volatility Surging for John B. Sanfilippo & Son Stock Options

Investors need to pay close attention to JBSS stock based on the movements in the options market lately. 

John B. Sanfilippo & Son, Inc. $JBSS Stock Position Lifted by Martin & Co. Inc. TN

Martin & Co. Inc. TN grew its position in John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS - Free Report) by 33.0% in the third quarter, according to its most recent 13F filing with the Securities and...

John B. Sanfilippo & Son, Inc. $JBSS Stake Boosted by Heartland Advisors Inc.

Heartland Advisors Inc. boosted its holdings in John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS - Free Report) by 450.0% in the third quarter, according to the company in its most recent Form 13F filing...

John B. Sanfilippo & Son, Inc. engages in the processing and distribution of nuts and nut-related products. It offers peanuts, pecans, cashews, walnuts, almonds, and other nuts under the brands of Fisher, Orchard Valley Harvest, Squirrel Brand, and Southern Style Nuts. The company was founded by Gaspare Sanfilippo and John B. Sanfilippo in 1922 and is headquartered in Elgin, IL.

Current Price	$81.22
Prev Close	$80.90
Open	$81.17
Dividend Yield	1.35%
50-Day Moving Average	$79.53
Beta	0.21
Avg. Volume	60,370.21
PE Ratio	13.55

52-Week High	$85.15
52-Week Low	$57.12
Market Capitalization	$945.46M
EPS (Annual)	$5.03
Price to Book	2.56
Revenue Per Employee	$582,761.05

JBSS
Sanfilippo (John B.) & Son, Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest JBSS News

JBSSSanfilippo (John B.) & Son, Inc